Pelthos Therapeutics PTHS
NYSE PTHS
$26.53 +0.69 (+2.67%)
At close: Aug 20, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) EPS (Basic) (2023 - 2026)

Pelthos Therapeutics (PTHS) posted quarterly EPS (Basic) of -$11.52 for Q4 2025, down 233.44% year-over-year from $8.63 in Q4 2024, and down 117.2% quarter-over-quarter from -$5.3 in Q3 2025.

Pelthos Therapeutics (PTHS) EPS (Basic) (2023 - 2026) Analysis & Trends

Pelthos Therapeutics' EPS (Basic) history runs 3 years deep, the most recent figure standing at -$11.52 for Q4 2025.

  • In Q4 2025, EPS (Basic) fell 233.44% year-over-year to -$11.52; the TTM figure through Dec 2025 stood at -$19.34 (down 35.53% YoY), while the FY2025 annual figure was -$23.04, down 61.42% from the prior year.
  • EPS (Basic) for Q4 2025 stood at -$11.52, down from -$5.3 in the prior quarter.
  • The five-year high for EPS (Basic) was $5.46 in Q2 2025, with the low at -$31.64 in Q4 2023.
  • The 3-year median for EPS (Basic) is -$5.38 (2025), against an average of -$7.81.
  • Peak annual rise in EPS (Basic) reached 278.08% in 2025, while the deepest fall reached 233.44% in 2025.
  • Pelthos Therapeutics' EPS (Basic) stood at -$31.64 in 2023, then jumped by 89.08% to -$3.46 in 2024, then slumped by 233.44% to -$11.52 in 2025.
  • Business Quant data shows PTHS's EPS (Basic) at -$11.52 in Q4 2025, -$5.3 in Q3 2025, and $5.46 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 12.62
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 7.59
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.23
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -0.06
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.18
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -0.72
10 Pelthos Therapeutics 96.56 Mn 72.00 Mn 21.23 Mn -13.70

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.70
Dec 31, 2025 -11.52
Sep 30, 2025 -5.30
Jun 30, 2025 5.46
Mar 31, 2025 -3.21
Dec 31, 2024 -3.46
Sep 30, 2024 -2.93
Jun 30, 2024 -3.07
Mar 31, 2024 -5.46
Dec 31, 2023 -31.64
Sep 30, 2023 -14.44
Jun 30, 2023 -9.51
Mar 31, 2023 -8.70